Mounjaro Injection Pen – 10 mg (Tirzepatide)
Mounjaro (tirzepatide) 10 mg Injection Pen is a once-weekly injectable medication designed to support blood glucose management and metabolic health in adults with type 2 diabetes. It contains tirzepatide, an advanced dual-action molecule that activates both GIP and GLP-1 receptors to regulate blood sugar levels, appetite, and digestion.
This dual-hormone mechanism helps the body release insulin when blood sugar rises, slows stomach emptying, and sends signals of fullness to the brain. These combined effects support improved glycemic control and may assist with weight reduction when used alongside proper diet and lifestyle changes.
$999.00 – $3,799.00Price range: $999.00 through $3,799.00
* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.
Everything You Need To Know
Metronidazole 400 mg is a systemic antimicrobial medication that works by disrupting DNA synthesis in susceptible anaerobic bacteria and protozoa, ultimately leading to the elimination of the infection. It is administered orally and absorbed through the gastrointestinal tract to reach effective therapeutic levels in infected tissues.
Metronidazole is not effective against viral or fungal infections and should only be used when clinically indicated and prescribed by a healthcare professional.
Under the supervision of a physician, metronidazole may be used for the management of:
Anaerobic bacterial infections, such as intra‑abdominal infections
Certain protozoal infections (e.g., giardiasis, trichomoniasis)
Bacterial vaginosis, when indicated by a clinician
Dental and periodontal infections involving anaerobic bacteria
Skin and soft tissue infections with susceptible organisms
Important: Metronidazole is not effective against viral illnesses such as the common cold or flu, and its use should be guided by clinical diagnosis.
Metronidazole should be taken exactly as directed by your healthcare provider:
Take tablets orally with a full glass of water.
The frequency and duration of treatment depend on the type and severity of the infection.
Complete the full course of therapy even if symptoms improve before finishing the medication — premature discontinuation can lead to incomplete treatment and recurrence.
Avoid alcohol consumption during treatment and for at least 48–72 hours after the last dose, as metronidazole can interact negatively with alcohol.
Always follow your clinician’s instructions regarding dosage, timing, and duration of treatment.
Before starting metronidazole, inform your healthcare provider about:
Medical history, including liver or kidney disease, neurological conditions, or blood disorders
Allergies to nitroimidazole antibiotics
Pregnancy or breastfeeding status (safety in pregnancy/breastfeeding should be evaluated by a clinician)
Current medications and supplements, as interactions can occur
Possible side effects may include nausea, metallic taste, headache, dizziness, or mild gastrointestinal discomfort. Serious reactions are rare but may include allergic reactions, neurological symptoms, or severe gastrointestinal issues — seek medical attention if you experience concerning symptoms.
Patients should be advised to avoid driving or operating heavy machinery if they experience dizziness or altered coordination.

Reviews
Clear filtersThere are no reviews yet.